Search Results

• • 3 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Beyond clinical trials in advanced soft tissue sarcoma: what to expect from trabectedin treatment?

  Author:Peter ReichardtFrom:Future Oncology (Vol. 11, Issue 11s) Peer-Reviewed

  June 2015339 words Brief article 1360LAuthor(s): Peter Reichardt [*] Trabectedin has mechanisms of action that differentiate it from conventional cytotoxic agents used in the treatment of advanced soft tissue sarcoma; the possibility that these multiple...

• Trabectedin clinical cases: use according to indication in diverse clinical scenarios

  Authors:Giovanni Grignani, Javier Martin-Broto, Markus Schuler, and Peter ReichardtFrom:Future Oncology (Vol. 11, Issue 11s) Peer-Reviewed

  June 20155,435 words Report 1550LAuthor(s): Giovanni Grignani aff1 , Javier Martín-Broto aff2 , Markus Schuler aff3 , Peter Reichardt [*] aff4 KEYWORDS clinical case studies; dosing guidelines; neoadjuvant chemotherapy; synovial sarcoma;...

• Optimizing the use of trabectedin for advanced soft tissue sarcoma in daily clinical practice

  Authors:Axel Le Cesne and Peter ReichardtFrom:Future Oncology (Vol. 11, Issue 11s) Peer-Reviewed

  June 20155,147 words Report 1660LAuthor(s): Axel Le Cesne [*] aff1 , Peter Reichardt aff2 KEYWORDS advanced soft tissue sarcoma; elderly patients; maintenance treatment; safety; trabectedin; treatment optimization Trabectedin is indicated for...